Last reviewed · How we verify

NCT04400526

Development of a Community-based Network for Drug Abusers

Status unknown NA Last updated 24 May 2021
What this trial tests

NA trial testing A video competition in Adolescent in 250 participants. Status unknown.

Timeline
1 September 2021
Primary endpoint
1 July 2023
30 September 2023

Quick facts

Lead sponsorThe Hong Kong Polytechnic University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationnon randomized
Designsingle group
Maskingnone
Primary purposehealth services research
Enrollment250
Start date1 September 2021
Primary completion1 July 2023
Estimated completion30 September 2023
Sites1 location across Hong Kong

Drugs / interventions tested

Conditions studied

Sponsor

The Hong Kong Polytechnic University

Who can join

Adults 13 to 18, any sex, with Adolescent. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Hidden drug abuse remains a significant concern for public health. An appropriate intervention is necessary to encourage hidden drug abusers to report their situations and seek professional help. This project aims to develop a community-based network to identify and refer hidden drug abusers in Hong Kong, and assess its effectiveness.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Development of a Community-Based Network to Promote Anti-Drug Messaging and Identify Hidden Drug Abusers in Hong Kong.
    Ho KY, Lam KWK, Tong ETF, Ho S, et al · · 2022 · cited 1× · PMID 36141826 · DOI 10.3390/ijerph191811544

Verify or expand the search:

Other recruiting trials for Adolescent

Currently open trials in the same condition.

Other The Hong Kong Polytechnic University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04400526.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing